Hepion Pharmaceuticals, Inc. (HEPA)
OTCMKTS · Delayed Price · Currency is USD
0.0880
0.00 (0.00%)
At close: Sep 8, 2026
Hepion Pharmaceuticals Market Cap
Hepion Pharmaceuticals has a market cap or net worth of $7.94 million as of September 8, 2026. Its market cap has increased by 775.93% in one year.
Market Cap
7.94M
Enterprise Value
8.01M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.09
ChartMarket Cap Chart
Since February 10, 2014, Hepion Pharmaceuticals's market cap has decreased from 13.86M to 7.94M, a decrease of -42.72%. That is a compound annual growth rate of -4.33%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 8, 2026 | 7.94M | 1,038.71% |
| Dec 31, 2025 | 697.22K | -78.69% |
| Dec 31, 2024 | 3.27M | -76.72% |
| Dec 29, 2023 | 14.05M | -38.61% |
| Dec 30, 2022 | 22.89M | -73.66% |
| Dec 31, 2021 | 86.90M | 23.90% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Brainstorm Cell Therapeutics | 11.59M |
| Zeo ScientifiX | 9.40M |
| Institute of Biomedical Research | 8.23M |
| OSR Health | 7.90M |
| Adaptimmune Therapeutics | 7.10M |
| Reviva Pharmaceuticals Holdings | 6.95M |
| TRON Group | 5.52M |
| Curative Biotechnology | 5.36M |